Release Date: 01/06/18 10:41 Summary: Commencement of Post-Consolidation Trading Price Sensitive: No Download Document 46.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%